R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Diana Al-Sarayfi, Frederik O. Meeuwes, M. jde Durmaz, Djamila E. Issa, Rolf E. Brouwer, Aart Beeker, Anna van Rhenen, Pim G. N. J. Mutsaers, Lara H. Böhmer, Marjolein W. M. van der Poel, Liane te Boome, Tom van Meerten, Martine E. D. Chamuleau, Josée M. Zijlstra, Mirian Brink, Marcel Nijland

Research output: Contribution to journalComment/Letter to the editorAcademic

1 Citation (Scopus)
Original languageEnglish
Article number125
Pages (from-to)125
JournalBlood Cancer Journal
Volume12
Issue number9
DOIs
Publication statusPublished - 1 Sept 2022

Cite this